Gene therapy in dermatology

Indian Journal of Dermatology

Volumn 51, Issue 3, 2006, Pages 211-216

  Sarma, Nilendu ^a,b  

^a Institute of Allergic and Immunologic Skin Diseases   (India)

^b P N Colony   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750716080     PISSN: 00195154     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5154.27992     Document Type: Review

References (61)

1. Khavari PA, Rollman O, Vahlquist A. Cutaneous gene transfer for skin and systemic diseases. J Intern Med 2002;252:1-10.
2. Baek SC, Lin Q, Robbins PB, Fan H, Khavari PA. Sustainable systemic delivery via a single injection of lentivirus into human skin tissue. Hum Gene Ther 2001;12:1551-8.
3. Wraight CJ, White PJ. Antisense oligonucleotides in cutaneous therapy. Pharmacol Ther 2001;90:89-104.
4. Lewin AS, Hauswirth WW. Ribozyme gene therapy: Applications for molecular medicine. Trends Mol Med 2001;7:221-8.
5. Robbins PB, Khavari PA. Strategies for cutaneous gene therapy. Curr Probl Dermatol 2000;12:198-203.
6. Hengge UR, Walker PS, Vogel JC. Expression of naked DNA in human, pig, and mouse skin. J Clin Invest 1996;97:2911-6.
7. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302:415-9.
8. Durai S, Mani M, Kandavelou K, Wu J, Porteus MH, Chandrasegaran S. Zinc finger nucleases: Custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucl Acids Res 2005;33:5978-90.
9. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994;91:4407-11.
10. Chen M, Li W, Fan J, Kasahara N, Woodley D. An efficient gene transduction systemfor studying gene function in primary human dermal fibroblast and epidermal keratinocytes. Clin Exp Dermatol 2003;28:193-9.
11. Distler JH, Jungel A, Kurowska-Stolarska M, Michel BA, Gay RE, Gay S, et al. Nucleofection: A new, highly efficient transfection method for primary human keratinocytes. Exp Dermatol 2005;14:315-20.
12. Mecklenbeck S, Compton SH, Mejia JE, Cervini R, Hovnanian A, Bruckner-Tuderman L, et al. A microinjected COL7A1-PAC vector restors synthesis of intact procollagen VII in a dystrohic epidermolysis bullosa keratinocytes cell line. Hum Gene Ther 2002:13:1655-62.
13. Hengge UR, Chan EF, Foster RA, Walder PS, Vogel JC. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Gen 1995;10:161-6.
14. Sawamura D, Meng X, Ina S, Ishikawa H, Tamai K, Nomura K, et al. In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method. J Invest Dermatol 1997;108:195-9.
15. Sawamura D, Yasukawa K, Kodama K, Yokota K, Sato-Matsumura KC, Toshihiro T, et al. The majority of keratinocytes incorporate intradermally injected plasmid DNA Regardless of size but only a small proportion of cells can express the gene product. J Invest Dermatol 2002;118:967-71.
16. Hengge UR, Tachakarjan E, Mirmohammdsadegh GM, Meyer HE. Uptake of DNA by keratinocytes. In: Hengge UR, Volc-Platzer B, editors. The Skin and Gene Therapy, 1st ed. Springer: Berlin; 2001. p. 81-94.
17. Ina S, Sawamura D, Meng X, Tamai K, Hanada K, Hashimoto I. In vivo gene transfer method in keratinocyte gene therapy. Intradermal injection of DNA complexed with high morbility-1 protein in rats. Acta Derm Venereol 2000;80:10-3.
18. Palmer TD, Rosman GJ, Osborne WR, Miller AD. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 1991;88:1330-4.
19. Khavari PA. Gene therapy for genetic skin disease. J Invest Dermatol 1998;110:462-7.
20. Trainer AM, Alexander MY. Gene delivery to the epidermis. Hum Mol Gen 1997;6:1761-7.
21. Donahue BA, McArthur JG, Spratt SK, Bohl D, Lagarde C, Sanchez L, et al. Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med 1999;1:31-42.
22. Ghazizadeh S, Harrington R, Taichman L. In vivo transduction of mouse epidermis with recombinant retroviral vectors: Implications for cutaneous gene therapy. Gene Ther 1999;6:1267-75.
23. th American Society of Gene Therapy Annual Meeting. Expert Opin Biol Ther 2006;6:839-42.
24. Ghazizadeh S, Kalish RS, Taichman LB. Immune mediated loss of transgene expression in skin: Implication for cutaneous gene therapy. Mol Ther 2003;7:296-303.
25. Tan PH, Butelspacher SC, Xue SA, Wang YH, Mitchell P, McAlister JC, et al. Modulation of human dendritic cell function following transduction with viral vectors: Implication for gene therapy. Blood 2005;105:3824-32.
26. Tan PH, Yates JB, Xue SA, Chan C, Jordan WJ, Harper JE, et al. Creation of tolerogenic human dendritic cells via intracellular CTLA4: A novel strategy with potential in clinical immunosuppression. Blood 2005;106:2936-43.
27. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-8.
28. Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996;380:717-20.
29. Zhao Y, Swenson K, Sergio JJ, Arn JS, Sachs DH, Sykes M. Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 1996;2:1211-6.
30. st ed. Springer: Hydelburg, Germany; 2001.
31. Greenhalgh DA, Rothnagel JA, Roop DR. Epidermis: An attractive target for gene therapy. J Invest Dermatol 1994;103:63S-9S.
32. Morgan JR, Barrandon Y, Green H, Mulligan RC. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 1987;237:1476-9.
33. Petersen MJ, Kaplan J, Jorgensen CM, Schmidt LA, Li L, Morgan JR, et al. Sustained production of human transferrin by transduced fibroblasts implanted into athymic mice: A model for somatic gene therapy. J Invest Dermatol 1995;104:171-6.
34. Fenjves ES, Gordon DA, Pershing LK, Williams DL, Taichman LB. Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: Implications for epidermal function and gene therapy. Proc Natl Acad Sci USA 1989;86:8803-7.
35. Gerrard AJ, Hudson DL, Brownlee GG, Watt FM. Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 1993;3:180-3.
36. Meng X, Sawamura D, Tamai K, Hanada K, Ishida H, Hashimoto I. Keratinocyte gene therapy for systemic disease. Circulating interleukin 10 released from gene transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. J Clin Invest 1998;101:1462-7.
37. Cao T, Wang XJ, Roop DR. Regulated cutaneous gene delivery: The skin as a bioreactor. Hum Gene Ther 2000;11:2297-300.
38. Katz AB, Taichman LB. A partial catalogue of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol 1999;112:818-21.
39. Meng X, Sawamura D, Ina S, et al. Keratinocyte gene therapy: Cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin. Exp Dermatol (in press).
40. Dunlap S, Yu X, Cheng L, Civin CI, Alani RM. High efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system. J Invest Dermatol 2004;122:549-51
41. Mathor MB, Ferrari G, Dellambra E, Cilli M, Mavilio F, Cancedda R, et al. Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci USA 1996;93:10371-6.
42. Mullen CA, Snitzer K, Culver KW, Morgan RA, Anderson WF, Blaese RM. Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: Long-term expression in vivo of genes introduced with a retroviral vector. Hum Gene Ther 1996;7:1123-9.
43. Vogel JC. Keratinocyte gene therapy. Arch Deramtol 1993;129:1478-83.
44. Terron A, McLean WH. Ribozyme gene therapy for keratin disorders. Acta Derm Venereol 2001;81:237.
45. D'Alessandro M, Morley SM, Ogden PH, Liovic M, Porter RM, Lane EB. Functional improvement of mutant keratin cells on addition of desmin: An alternative approach to gene therapy for dominant diseases. Gene Ther 2004;11:1290-5.
46. Ferrari S, Pellegrini G, Matsui T, Mavilio F, De Luca M. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa. Exp Opin Biol Ther 2006;6:367-78.
47. Ortiz-Urda S, Lin Q, Yant SR, Keene D, Kay MA, Khavari PA. Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer. Gene Ther 2003;10:1099-104.
48. Robbins PB, Lin Q, Goodnough JB, Tian H, Chen X, Khavari PA. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci USA 2001;98:5193-8.
49. Seitz CS, Giudice GJ, Balding SD, Marinkovich MP, Khavari PA. BP180 gene delivery in junctional epidermolysis bullosa. Gene Ther 1999;6:42-7.
50. Goto M, Sawamura D, Ito K, Abe M, Nishie W, Sakai K, et al. Fibroblast show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. J Invest Dermatol 2006;126:766-72.
51. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
52. Costa RM, Chigancas V, Galhardorda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repair pathway. Biochimie 2003;85:1083-99.
53. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 1996;272:263-7.
54. Marchetto MC, Correa RG, Menck CF, Muotri AR. Functional lentiviral vectors for xeroderma pigmentosum gene therapy. J Biotechnol 2006 [Epub ahead of print].
55. Carreau M, Quillet X, Eveno E, Salvetti A, Danos O, Heard JM, et al. Functional retroviral vector for gene therapy of Xeroderma group B patients. Hum Gene Ther 1995;6:1308-15.
56. Choate KA, Kinsella TM, Wiliams ML, Nolan GP, Khavari PA. Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. Hum. Gene Ther 1996;7:2247-53.
57. Choate KA, Medalie DA, Morgan JR, Khavari PA. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 1996;2:1263-7.
58. Andree C, Swain WF, Page CP, Macklin MD, Slama J, et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 1994;91:12188-92.
59. Tyrone JW, Mogford JE, Chandler LA, Ma C, Xia Y, Pierce GF, et al. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J Surg Res 2000;93:230-6.
60. Liechty KW, Nesbit M, Herlyn M, Radu A, Adzick NS, Crombleholme TM. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 1999;113:375-83.
61. O'Malley BW Jr, Chen SH, Schwartz MR, Woo SL. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 1995;55:1080-5.